Mr Stuglik is a global leader in the oncology pharmaceutical sector, having successfully developed, acquired, and launched several important oncology products.

Mr. Stuglik founded Proventus Health Solutions in January 2016 and has over three decades of experience in U.S. and international pharmaceutical development, ...

Brian Stuglik, RPh. Mr Stuglik served as the Chief Executive Officer (CEO) of Verastem Oncology from 2019 through 2023. Mr Stuglik is a global leader in the ...

Mr. Stuglik is a global leader in the oncology pharmaceutical sector with over 3 decades of experience in US and International pharmaceutical development.

Brian Michael Stuglik is Former Chief Executive Officer at Verastem Inc. See Brian Michael Stuglik's compensation, career history, education, & memberships.

há 8 dias · Brian M. Stuglik, who serves as a director at Verastem, has sold a portion of his holdings in the company. The transaction, which took place on ...

11 de jul. de 2023 · Brian Stuglik has been the CEO of Verastem Oncology since 2019 and a member of the Board of Directors since 2017. He has been instrumental in ...

21 de jun. de 2024 · The estimated Net Worth of Brian M Stuglik is at least $2.47 Million dollars as of 17 June 2024. Mr. Stuglik owns over 928 units of Verastem Inc ...

18 de set. de 2024 · Verastem, Inc. (NASDAQ:VSTM) director Brian M. Stuglik recently sold shares in the company, according to a new SEC filing.